Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(85.7%)
Phase 3
1(14.3%)
7Total
N/A(6)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT02612532Not ApplicableCompleted

Lung Cancer Indicator Detection

Role: collaborator

NCT02998359Not ApplicableCompleted

Hemiarthroplasty Versus Total Hip Replacement for Intracapsular Hip Fractures

Role: lead

NCT02680028Not ApplicableCompleted

Short Versus Standard Intramedullary Nail for Trochanteric Hip Fractures

Role: lead

NCT02998034Not ApplicableCompleted

Cemented Hemiarthroplasty Versus Uncemented Furlong Hemiarthroplasty

Role: lead

NCT03172923Not ApplicableCompleted

Nail Versus Sliding Hip Screw for Trochanteric Hip Fractures

Role: lead

NCT02996383Not ApplicableUnknown

Fixation Versus Arthroplasty for Undisplaced Intracapsular Fractures

Role: lead

NCT00919230Phase 3Completed

Randomised Trial Comparing Iron Supplementation Versus Placebo in the Treatment of Anaemia After Hip Fracture

Role: lead

All 7 trials loaded